XIL Health Rebrands with Expanded Offerings, Bringing 32+ Years of Experience and Pioneering Technologies to Empower Innovative Healthcare Startups

As one of the nation’s leading strategic pharmacy economics experts, XIL Health provides actionable insights to encourage organizations, including retail pharmacies, PBMs and healthcare startups, to optimize in an unpredictable market

XIL Health, a leading strategic analytics and technology company in the drug economics space, announced that it is expanding its services to assist healthcare startups to rapidly penetrate the market. Traditionally, XIL Health partners with pharmacy benefit managers (PBMs), retail pharmacies, hospitals, infusion companies and specialty pharmacies to stabilize, optimize and innovate in a market that is dominated by Fortune 100 companies. This creates an uneven playing field for startups focused on innovation.

Working closely with funded startups in the pharmacy access area, CEO Susan L. Lang, a former C-suite executive with Express Scripts, realized how disadvantaged startups are, regardless of funding. “Creating market fit for your product or service is difficult in any industry, but the massive consolidation within the PBM space makes it virtually impossible for smaller companies to compete,” said Lang.

Recommended AI News: Liquid Mortgage Raises Seed Round Funding to Further Develop Its Blockchain Technology for the Future of the Mortgage Industry

The team at XIL Health has previously managed PBMs or pharmacies so they understand how to rapidly scale using real-time metrics, mine data for pivots and provide insights into market structure that help startups disrupt the market and win.

Alexandra Robertson, VP Client Growth and Innovation at XIL Health, says, “It’s all about creating the right incentives for alignment when trying to figure out the complex matrix of PBMs and drug access.”

Recommended AI News: Circle Selects Signature Bank for USDC Integration and Reserve Balances

With more than 32 years of experience in pharmaceuticals, XIL Health has advised more than 40 top tier healthcare brands, including eight Fortune 100 companies, multiple PBMs and more than 16 pharmacy chains, partnering with both publicly traded and private equity companies to optimize their service offerings as well as their economics. When traditional strategies fail, XIL Health has consistently served as a trusted advisor to the pharmaceutical industry with real-time analytics that more precisely account for rapidly changing market forces.

XIL Health provides results-driven insights through its individualized playbook and its innovative technology solutions.

Recommended AI News: Google Cloud Support Now Available on Crunchy Bridge